An exploratory study showed a 56% seizure reduction in the maintenance period for 10 subjects on 3-4 mg doses, increasing to 66% in the post-maintenance extension.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
An exploratory study showed a 56% seizure reduction in the maintenance period for 10 subjects on 3-4 mg doses, increasing to 66% in the post-maintenance extension.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.